Role of lysophosphatidic acid (LPA) and LPA1 receptor in the treatment of bone metastases in breast cancer

被引：0
|
作者：
Boucharaba, A.
Menaa, F.
Clezardin, P.
Peyruchaud, O.
机构：
[1] INSERM, U664, Mecanismes & Traitements Metastases Osseuses Tume, F-69372 Lyon 08, France
[2] Sidney Kimmel Canc Ctr, San Diego, CA 93121 USA
来源：
BULLETIN DU CANCER | 2007年 / 94卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
102
引用
收藏
页码：560 / 561
页数：2
相关论文
共 50 条
  • [41] Involvement of lysophosphatidic acid (LPA) in rat bone cancer pain
    Pan, Hai L.
    Zhao, Jun
    NEUROSCIENCE RESEARCH, 2010, 68 : E425 - E425
  • [42] Initial structure-activity relationships of lysophosphatidic acid receptor antagonists:: discovery of a high-affinity LPA1/LPA3 receptor antagonist
    Heasley, BH
    Jarosz, R
    Lynch, KR
    Macdonald, TL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) : 2735 - 2740
  • [43] Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex
    Beatriz García-Díaz
    Raquel Riquelme
    Isabel Varela-Nieto
    Antonio Jesús Jiménez
    Isabel de Diego
    Ana lsabel Gómez-Conde
    Elisa Matas-Rico
    José Ángel Aguirre
    Jerold Chun
    Carmen Pedraza
    Luis Javier Santín
    Oscar Fernández
    Fernando Rodríguez de Fonseca
    Guillermo Estivill-Torrús
    Brain Structure and Function, 2015, 220 : 3701 - 3720
  • [44] PPARγ1 but not LPA1 and LPA2 GPCR are required for neointima formation induced by lysophosphatidic acid and rosiglitazone in mice
    Tigyi, Gabor
    Cheng, Yunhui
    Tsukahara, Tamotsu
    Zhang, Chunxiang
    Balazs, Louisa
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E85 - E85
  • [45] A dual lysophosphatidic acid (LPA) antagonist (LPA1/LPA3), VPC 12249, reduces renal ischemia-reperfusion injury (IRI).
    Okusa, MD
    Ye, H
    Huang, LP
    Heise, CE
    Santos, WL
    Macdonald, T
    Lynch, KR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 140A - 140A
  • [46] Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
    Cheng, Peter T. W.
    Kaltenbach, Robert F.
    Zhang, Hao
    Shi, Jun
    Tao, Shiwei
    Li, Jun
    Kennedy, Lawrence J.
    Walker, Steven J.
    Shi, Yan
    Wang, Ying
    Dhanusu, Suresh
    Reddigunta, Ramesh
    Kumaravel, Selvakumar
    Jusuf, Sutjano
    Smith, Daniel
    Krishnananthan, Subramaniam
    Li, Jianqing
    Wang, Tao
    Heiry, Rebekah
    Sum, Chi Shing
    Kalinowski, Stephen S.
    Hung, Chen-Pin
    Chu, Ching-Hsuen
    Azzara, Anthony, V
    Ziegler, Milinda
    Burns, Lisa
    Zinker, Bradley A.
    Boehm, Stephanie
    Taylor, Joseph
    Sapuppo, Julia
    Mosure, Kathy
    Everlof, Gerry
    Guarino, Victor
    Zhang, Lisa
    Yang, Yanou
    Ruan, Qian
    Xu, Carrie
    Apedo, Atsu
    Traeger, Sarah C.
    Cvijic, Mary Ellen
    Lentz, Kimberley A.
    Tirucherai, Giridhar
    Sivaraman, Lakshmi
    Robl, Jeffrey
    Ellsworth, Bruce A.
    Rosen, Glenn
    Gordon, David A.
    Soars, Matthew G.
    Gill, Michael
    Murphy, Brian J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 15549 - 15581
  • [47] Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1
    Shida, D
    Kitayama, J
    Yamaguchi, H
    Okaji, Y
    Tsuno, NH
    Watanabe, T
    Takuwa, Y
    Nagawa, H
    CANCER RESEARCH, 2003, 63 (07) : 1706 - 1711
  • [48] Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex
    Garcia-Diaz, Beatriz
    Riquelme, Raquel
    Varela-Nieto, Isabel
    Jesus Jimenez, Antonio
    de Diego, Isabel
    lsabel Gomez-Conde, Ana
    Matas-Rico, Elisa
    Angel Aguirre, Jose
    Chun, Jerold
    Pedraza, Carmen
    Javier Santin, Luis
    Fernandez, Oscar
    Rodriguez de Fonseca, Fernando
    Estivill-Torrus, Guillermo
    BRAIN STRUCTURE & FUNCTION, 2015, 220 (06): : 3701 - 3720
  • [49] Defective myelination in mice lacking the lysophosphatidic acid receptor LPA1:: newcomer models for demyelinating diseases
    Garcia-Diaz, B.
    Matas-Rico, E.
    Riquelme, R.
    Varela-Nieto, I.
    Jimenez, A. J.
    Chun, J.
    Leyva, L.
    Fernandez, O.
    Rodriguez de Fonseca, F.
    Estivill-Torrus, G.
    MULTIPLE SCLEROSIS, 2007, 13 : S258 - S258
  • [50] Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells
    Fukushima, Kaori
    Takahashi, Kaede
    Yamasaki, Eri
    Onishi, Yuka
    Fukushima, Nobuyuki
    Honoki, Kanya
    Tsujiuchi, Toshifumi
    EXPERIMENTAL CELL RESEARCH, 2017, 352 (01) : 139 - 145
12345